» Articles » PMID: 36819657

Racial Disparities in the Genetic Landscape of Lung Cancer

Overview
Date 2023 Feb 23
PMID 36819657
Authors
Affiliations
Soon will be listed here.
Abstract

Lung cancer has the highest cancer-related mortality worldwide and in the United States. Although reduced tobacco consumption and advancement in therapies have led to a modest decline in lung cancer death rates over the past two decades; the overall survival rate is still disappointing. Moreover, race-associated disparities are also observed, especially in the clinical outcomes. Socioeconomic factors are considered major contributors in cancer health disparities, however, the differences in the genetic landscape of lung cancer among different racial groups have also been reported. In this review, we shed light on the genetic heterogeneity of lung cancer and race-associated differences in genetic alterations to build a framework for future studies to understand the biological basis of lung cancer disparities.

Citing Articles

Ethnic disparities in lung cancer incidence and differences in diagnostic characteristics: a population-based cohort study in England.

Chen D, Hirst J, Coupland C, Liao W, Baldwin D, Hippisley-Cox J Lancet Reg Health Eur. 2024; 48:101124.

PMID: 39583943 PMC: 11584601. DOI: 10.1016/j.lanepe.2024.101124.

References
1.
Vu T, Jin L, Datta P . Effect of Cigarette Smoking on Epithelial to Mesenchymal Transition (EMT) in Lung Cancer. J Clin Med. 2016; 5(4). PMC: 4850467. DOI: 10.3390/jcm5040044. View

2.
Lu J, Sharma L, Bai Y . Implications of mitochondrial DNA mutations and mitochondrial dysfunction in tumorigenesis. Cell Res. 2009; 19(7):802-15. PMC: 4710094. DOI: 10.1038/cr.2009.69. View

3.
Harada T, Lopez-Chavez A, Xi L, Raffeld M, Wang Y, Giaccone G . Characterization of epidermal growth factor receptor mutations in non-small-cell lung cancer patients of African-American ancestry. Oncogene. 2010; 30(15):1744-52. PMC: 7213757. DOI: 10.1038/onc.2010.545. View

4.
Rivlin N, Brosh R, Oren M, Rotter V . Mutations in the p53 Tumor Suppressor Gene: Important Milestones at the Various Steps of Tumorigenesis. Genes Cancer. 2011; 2(4):466-74. PMC: 3135636. DOI: 10.1177/1947601911408889. View

5.
Chaban Y, Boekema E, Dudkina N . Structures of mitochondrial oxidative phosphorylation supercomplexes and mechanisms for their stabilisation. Biochim Biophys Acta. 2013; 1837(4):418-26. DOI: 10.1016/j.bbabio.2013.10.004. View